Tumor microenvironment conversion through intelligent nanomedicine: a paradigm shift in overcoming chemoresistance - Top-Institutions - MDSpire

Tumor microenvironment conversion through intelligent nanomedicine: a paradigm shift in overcoming chemoresistance

By
Maliheh Hasannia
Mahdi Abounoori
Fatemeh Mahmoudian
Maryam Shirzad
Abbas Rahdar
Selamu Duguna
Sadanand Pandey
June 17, 2026
0 min

Frontiers In Oncology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

The University of Texas MD Anderson Cancer Center

Houston, Texas
Key Differentiators
- Oncology
- Nanomedicine
#2

Imperial College of London

London, England
Key Differentiators
- Oncology
- Nanomedicine
#3

University of California, Los Angeles (UCLA)

Los Angeles, California
Key Differentiators
- Oncology
- Nanomedicine
#4

Chan Soon-Shiong Institute of Molecular Medicine

Los Angeles, California
Key Differentiators
- Oncology
- Nanomedicine
#5

University of Oxford

Oxford, England
Key Differentiators
- Oncology
- Nanomedicine

Original Source(s)

Frontiers In Oncology

Tumor microenvironment conversion through intelligent nanomedicine: a paradigm shift in overcoming chemoresistance

by Maliheh Hasannia, Mahdi Abounoori, Fatemeh Mahmoudian, Maryam Shirzad, Abbas Rahdar, Selamu Duguna, Sadanand Pandey
June 17, 2026

Related Content

Frontiers In Immunology

The regulatory roles of dysregulated lactate dehydrogenase A in anti-tumor immunity within immune cells

by Xiaole Song, Shitong Lin, Qianwen Liu, Xuerou Chen, Yajuan Ma, Xiaoran Zhang, Fang Ren
June 17, 2026

Frontiers In Oncology

Malignant transformation of uterine serosal endometriosis to clear cell carcinoma in a postmenopausal patient: a rare case report

by Xiaodong Mi, Tong Lin, Xiaogang Zhu, Qian Chen, Xihan Yang, Purun Zou, Dan Shu, Fei Tuo
June 17, 2026

Frontiers In Pediatrics

Case Report: Reversible myelodysplastic syndrome secondary to sodium valproate in an epileptic child

by Hongyu Huang, Jiao Chen, Lei Ye, Dan Yu
June 17, 2026